Following the clearance of an investigational new drug application from the FDA, a phase 1 trial will examine the novel ...

The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...

With the reelection of Donald Trump, we could be looking at further erosion of any semblance of oversight of supplements on ...

It’s hard to know exactly what change in Washington will mean for the health care industry starting next year. But we have ...

REMS programmes are typically implemented after drug approval when the FDA determines that a medication needs to be closely ...

The integration of AI into drug submission and approval processes signifies a shift towards more efficient pharmaceutical ...

sided with industry when it issued its Bioengineered Food labeling regime in 2018. Trump’s USDA also relaxed school nutrition ...

Actor Prateik Babbar candidly discussed his first experience with drugs and the impact it had on both his personal life and ...

Drug shortages in the U.S. are increasing in number and duration, primarily affecting generic and multi-sourced drugs that ...

Prioritize and focus resources on LNCB74 (B7-H4 ADC) with a planned IND submission by year-endCash of approximately $75 million expected to fund operations into second half of 2026 BELTSVILLE, Md., ...

CFO Joel Grade told investors Friday that Baxter expects an approximately $200 million hit to sales in the fourth quarter ...